Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead
Information source: Guidant Corporation
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Ventricular Tachycardia; Ventricular Fibrillation
Intervention: Endotak Reliance G (Device)
Phase: Phase 4
Status: Active, not recruiting
Sponsored by: Guidant Corporation Official(s) and/or principal investigator(s): Philippe Mabo, MD, Principal Investigator, Affiliation: Hôpital Pontchaillou, Rennes, France
Summary
The purpose of this study is to determine the safety and efficacy of the implant of a ICD
lead of defibrillation in the septum of the right ventricle
Clinical Details
Official title: Evaluation of the Success Rate and the Clinical Evolution of a Ventricular Lead Implanted in the Septum Versus the Right Ventricular Apex.
Study design: Other, Randomized, Single Blind (Subject), Uncontrolled, Parallel Assignment
Primary outcome: Implant success rate at septal site
Secondary outcome: Adverse events and effects related to defibrillation lead during 5 year follow-upNumber of successful low energy shocks in VT zone during 1 year follow-up Evolution of LVEF Overall adverse events and effects
Detailed description:
The rate of success at implant and the positive clinical outcomes for the patients implanted
with a lead of defibrillation at the septal site would make it possible to recommend this
site as a "new standard" for implant of the defibrillation lead in the RV for ICD.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- ICD indication according to current Guidelines
Exclusion Criteria:
- Indication for cardiac resynchronisation therapy, absence of spontaneous ventricular
rhythm, pacemaker dependency
Locations and Contacts
Hôpital Pontchaillou, Rennes, France
CHU Michalon, Grenoble 38043, France
CHU Angers, Angers 49033, France
CHU Tours, Tours 37044, France
CHU Montpellier, Montpellier 34295, France
Nouvelle Clinique Nantaise, Nantes 34295, France
CHU Nantes, Nantes 34295, France
CHU Lariboisière, Paris 75010, France
HEGP, Paris 75908, France
CHU Pitié Salpitrière, Paris 75013, France
CHU Rangueil, Toulouse 31403, France
CHU Rouen, Rouen 76031, France
CHU Clermont Ferrand, Clermont Ferrand 63003, France
CHU Henri Mandor, Créteil 94010, France
CHU La Timone, Marseille 13385, France
CH St. Joseph, Marseille 13008, France
CH Amiens, Amiens 80054, France
CH Besancon, Besancon 25030, France
Additional Information
Starting date: April 2005
Ending date: November 2011
Last updated: December 12, 2007
|